[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Impact of Obstructive Sleep Apnea on In-Hospital Outcomes in Patients with Renal Failure",
    "section": "",
    "text": "Study Objective: Investigate the association between obstructive sleep apnea (OSA) and in-hospital outcomes in patients admitted with a diagnosis of renal failure across U.S. hospitals from 2018 to 2020, adjusting for demographic, clinical, and hospital factors.\nData Source: Cross-sectional analysis using the National Inpatient Sample (NIS) from 2018 to 2020, a nationwide database that captures inpatient admissions in the U.S., and is weighted to provide nationally representative estimates.\nPatient Selection: Included all inpatient admissions with a diagnosis of renal failure, identified using ICD-10-CM codes N18.5xx (Stage 5 CKD) and N18.6xx (ESRD). Patients were categorized based on the presence or absence of obstructive sleep apnea, identified using ICD-10-CM code G47.33.\nOutcomes of Interest:\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSecondary Outcomes:\n\nCardiac arrest\nGastrointestinal hemorrhage\n\n\nAdjustment Variables:\n\nDemographics and Socioeconomic Factors: Age, sex, race, residential income quartile.\nHospital Characteristics: Region, bed size, and teaching status.\nClinical Factors: Kidney transplant history, coronary artery disease, cerebrovascular disease, chronic obstructive pulmonary disease, diabetes mellitus, heart failure, hypertension, obesity, and Charlson Comorbidity Index.\n\nStatistical Analysis:\n\nUnivariable Analysis:\n\nContinuous Outcomes: Design-based Kruskal-Wallis test for outcomes such as length of stay and total charges.\nCategorical Outcomes: Rao & Scott-adjusted Pearson’s Chi-square test for outcomes like in-hospital mortality, gastrointestinal bleeding, and cardiac arrest.\n\nMultivariable Analysis:\n\nLogistic Regression: For binary outcomes (e.g., in-hospital mortality, gastrointestinal bleeding, cardiac arrest). Report adjusted odds ratios (ORs) with 95% confidence intervals (CIs).\nLinear Regression: For continuous outcomes (e.g., length of stay, total charges). Report adjusted beta coefficients with 95% CIs.\n\nModel Adjustment: All models adjusted for the demographic, clinical, and hospital factors listed above, as well as OSA status (yes/no).\nSurvey Weights: The NIS survey design and discharge weights were applied to account for the complex sampling methodology and ensure nationally representative estimates.\n\nSoftware: All analyses were conducted using the R Statistical Language (Version 4.4.1; R Foundation for Statistical Computing, Vienna, Austria), utilizing the survey package to account for complex sampling designs of the NIS."
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Impact of Obstructive Sleep Apnea on In-Hospital Outcomes in Patients with Renal Failure",
    "section": "",
    "text": "Study Objective: Investigate the association between obstructive sleep apnea (OSA) and in-hospital outcomes in patients admitted with a diagnosis of renal failure across U.S. hospitals from 2018 to 2020, adjusting for demographic, clinical, and hospital factors.\nData Source: Cross-sectional analysis using the National Inpatient Sample (NIS) from 2018 to 2020, a nationwide database that captures inpatient admissions in the U.S., and is weighted to provide nationally representative estimates.\nPatient Selection: Included all inpatient admissions with a diagnosis of renal failure, identified using ICD-10-CM codes N18.5xx (Stage 5 CKD) and N18.6xx (ESRD). Patients were categorized based on the presence or absence of obstructive sleep apnea, identified using ICD-10-CM code G47.33.\nOutcomes of Interest:\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSecondary Outcomes:\n\nCardiac arrest\nGastrointestinal hemorrhage\n\n\nAdjustment Variables:\n\nDemographics and Socioeconomic Factors: Age, sex, race, residential income quartile.\nHospital Characteristics: Region, bed size, and teaching status.\nClinical Factors: Kidney transplant history, coronary artery disease, cerebrovascular disease, chronic obstructive pulmonary disease, diabetes mellitus, heart failure, hypertension, obesity, and Charlson Comorbidity Index.\n\nStatistical Analysis:\n\nUnivariable Analysis:\n\nContinuous Outcomes: Design-based Kruskal-Wallis test for outcomes such as length of stay and total charges.\nCategorical Outcomes: Rao & Scott-adjusted Pearson’s Chi-square test for outcomes like in-hospital mortality, gastrointestinal bleeding, and cardiac arrest.\n\nMultivariable Analysis:\n\nLogistic Regression: For binary outcomes (e.g., in-hospital mortality, gastrointestinal bleeding, cardiac arrest). Report adjusted odds ratios (ORs) with 95% confidence intervals (CIs).\nLinear Regression: For continuous outcomes (e.g., length of stay, total charges). Report adjusted beta coefficients with 95% CIs.\n\nModel Adjustment: All models adjusted for the demographic, clinical, and hospital factors listed above, as well as OSA status (yes/no).\nSurvey Weights: The NIS survey design and discharge weights were applied to account for the complex sampling methodology and ensure nationally representative estimates.\n\nSoftware: All analyses were conducted using the R Statistical Language (Version 4.4.1; R Foundation for Statistical Computing, Vienna, Austria), utilizing the survey package to account for complex sampling designs of the NIS."
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Impact of Obstructive Sleep Apnea on In-Hospital Outcomes in Patients with Renal Failure",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall N = 3,385,7551\nRenal Failure without OSA N = 3,022,9001\nRenal Failure with OSA N = 362,8551\np-value2\n\n\n\n\nAge, y\n62 (15)\n62 (15)\n63 (12)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n&lt;0.001\n\n\n    Female\n1,537,500 (45%)\n1,397,280 (46%)\n140,220 (39%)\n\n\n\n\n    Male\n1,848,165 (55%)\n1,625,530 (54%)\n222,635 (61%)\n\n\n\n\nRace\n\n\n\n\n\n\n&lt;0.001\n\n\n    White\n1,380,020 (42%)\n1,196,370 (40%)\n183,650 (52%)\n\n\n\n\n    Asian or Pacific Islander\n138,215 (4.2%)\n128,165 (4.3%)\n10,050 (2.8%)\n\n\n\n\n    Black\n1,105,220 (33%)\n989,245 (33%)\n115,975 (33%)\n\n\n\n\n    Hispanic\n558,465 (17%)\n522,820 (18%)\n35,645 (10%)\n\n\n\n\n    Other\n141,300 (4.3%)\n131,705 (4.4%)\n9,595 (2.7%)\n\n\n\n\nResidential income\n\n\n\n\n\n\n&lt;0.001\n\n\n    $1 - $51,999\n1,297,295 (39%)\n1,171,690 (39%)\n125,605 (35%)\n\n\n\n\n    $52,000 - $65,999\n858,270 (26%)\n762,255 (26%)\n96,015 (27%)\n\n\n\n\n    $66,000 - $87,999\n692,500 (21%)\n612,270 (21%)\n80,230 (22%)\n\n\n\n\n    $88,000 or more\n482,110 (14%)\n425,735 (14%)\n56,375 (16%)\n\n\n\n\nInsurance payer\n\n\n\n\n\n\n&lt;0.001\n\n\n    Medicaid\n429,845 (13%)\n402,960 (13%)\n26,885 (7.4%)\n\n\n\n\n    Medicare\n2,471,650 (73%)\n2,186,840 (72%)\n284,810 (79%)\n\n\n\n\n    Other\n113,830 (3.4%)\n104,920 (3.5%)\n8,910 (2.5%)\n\n\n\n\n    Private\n367,220 (11%)\n325,285 (11%)\n41,935 (12%)\n\n\n\n\nHospital region\n\n\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n673,010 (20%)\n564,770 (19%)\n108,240 (30%)\n\n\n\n\n    Northeast\n555,475 (16%)\n503,840 (17%)\n51,635 (14%)\n\n\n\n\n    South\n1,475,535 (44%)\n1,333,720 (44%)\n141,815 (39%)\n\n\n\n\n    West\n681,735 (20%)\n620,570 (21%)\n61,165 (17%)\n\n\n\n\nHospital bedsize\n\n\n\n\n\n\n&lt;0.001\n\n\n    Large\n1,776,065 (52%)\n1,576,025 (52%)\n200,040 (55%)\n\n\n\n\n    Medium\n985,185 (29%)\n885,455 (29%)\n99,730 (27%)\n\n\n\n\n    Small\n624,505 (18%)\n561,420 (19%)\n63,085 (17%)\n\n\n\n\nHospital location/teaching status\n\n\n\n\n\n\n&lt;0.001\n\n\n    Rural\n174,185 (5.1%)\n155,975 (5.2%)\n18,210 (5.0%)\n\n\n\n\n    Urban, non-teaching\n602,090 (18%)\n546,315 (18%)\n55,775 (15%)\n\n\n\n\n    Urban, teaching\n2,609,480 (77%)\n2,320,610 (77%)\n288,870 (80%)\n\n\n\n\nKidney transplant Hx\n71,600 (2.1%)\n63,945 (2.1%)\n7,655 (2.1%)\n&gt;0.9\n\n\nCoronary artery disease\n1,442,975 (43%)\n1,250,625 (41%)\n192,350 (53%)\n&lt;0.001\n\n\nCerebrovascular disease\n301,515 (8.9%)\n272,070 (9.0%)\n29,445 (8.1%)\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n821,050 (24%)\n680,090 (22%)\n140,960 (39%)\n&lt;0.001\n\n\nDiabetes mellitus\n2,169,300 (64%)\n1,901,405 (63%)\n267,895 (74%)\n&lt;0.001\n\n\nHeart failure\n1,704,180 (50%)\n1,475,125 (49%)\n229,055 (63%)\n&lt;0.001\n\n\nHypertension\n3,212,090 (95%)\n2,863,345 (95%)\n348,745 (96%)\n&lt;0.001\n\n\nObesity\n617,580 (18%)\n457,975 (15%)\n159,605 (44%)\n&lt;0.001\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Impact of Obstructive Sleep Apnea on In-Hospital Outcomes in Patients with Renal Failure",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall N = 3,385,7551\nRenal Failure without OSA N = 3,022,9001\nRenal Failure with OSA N = 362,8551\np-value2\n\n\n\n\nDied during hospitalization\n182,145 (5.4%)\n167,595 (5.5%)\n14,550 (4.0%)\n&lt;0.001\n\n\nCardiac arrest\n80,210 (2.4%)\n73,245 (2.4%)\n6,965 (1.9%)\n&lt;0.001\n\n\nGastrointestinal hemorrhage\n284,705 (8.4%)\n254,620 (8.4%)\n30,085 (8.3%)\n0.2\n\n\nLength of stay (days)\n4.0 (2.0, 8.0)\n4.0 (2.0, 8.0)\n5.0 (3.0, 8.0)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n51,600 (27,248, 104,284)\n51,542 (27,132, 104,617)\n52,011 (28,186, 101,495)\n0.2\n\n\n\n1 n (%); Median (Q1, Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Impact of Obstructive Sleep Apnea on In-Hospital Outcomes in Patients with Renal Failure",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR1\n95% CI1\np-value\n\n\n\n\nObstructive sleep apnea status\n\n\n\n\n\n\n\n\n    Renal Failure without OSA\n—\n—\n\n\n\n\n    Renal Failure with OSA\n0.72\n0.69, 0.75\n&lt;0.001\n\n\nAge, y\n1.03\n1.03, 1.03\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.05\n1.02, 1.07\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.96\n0.91, 1.02\n0.2\n\n\n    Black\n0.90\n0.87, 0.92\n&lt;0.001\n\n\n    Hispanic\n0.94\n0.90, 0.98\n0.003\n\n\n    Other\n1.10\n1.03, 1.16\n0.002\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.94\n0.91, 0.96\n&lt;0.001\n\n\n    $66,000 - $87,999\n0.90\n0.87, 0.93\n&lt;0.001\n\n\n    $88,000 or more\n0.91\n0.87, 0.94\n&lt;0.001\n\n\nInsurance payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n0.98\n0.94, 1.02\n0.3\n\n\n    Other\n1.64\n1.53, 1.77\n&lt;0.001\n\n\n    Private\n1.20\n1.14, 1.26\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.09\n1.03, 1.14\n&lt;0.001\n\n\n    South\n1.04\n1.00, 1.08\n0.062\n\n\n    West\n1.16\n1.11, 1.22\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.98\n0.94, 1.01\n0.2\n\n\n    Small\n0.89\n0.86, 0.93\n&lt;0.001\n\n\nHospital location/teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.01\n0.95, 1.09\n0.7\n\n\n    Urban, teaching\n1.13\n1.06, 1.21\n&lt;0.001\n\n\nKidney transplant Hx\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.77, 0.92\n&lt;0.001\n\n\nRenal_Dialysis\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.49\n0.48, 0.50\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.05\n1.02, 1.07\n&lt;0.001\n\n\nCerebrovascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.40\n1.35, 1.44\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.79\n0.77, 0.81\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.64\n0.63, 0.66\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.29\n1.26, 1.33\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.43\n0.41, 0.45\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.89\n0.86, 0.92\n&lt;0.001\n\n\nCharlson comorbidity index\n1.17\n1.17, 1.18\n&lt;0.001\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nCardiac Arrest:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR1\n95% CI1\np-value\n\n\n\n\nObstructive sleep apnea status\n\n\n\n\n\n\n\n\n    Renal Failure without OSA\n—\n—\n\n\n\n\n    Renal Failure with OSA\n0.74\n0.70, 0.78\n&lt;0.001\n\n\nAge, y\n1.00\n1.00, 1.01\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.13\n1.10, 1.17\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.20\n1.11, 1.31\n&lt;0.001\n\n\n    Black\n1.22\n1.17, 1.27\n&lt;0.001\n\n\n    Hispanic\n1.18\n1.12, 1.25\n&lt;0.001\n\n\n    Other\n1.25\n1.15, 1.36\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.92\n0.89, 0.96\n&lt;0.001\n\n\n    $66,000 - $87,999\n0.88\n0.84, 0.92\n&lt;0.001\n\n\n    $88,000 or more\n0.88\n0.84, 0.93\n&lt;0.001\n\n\nInsurance payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n1.07\n1.01, 1.14\n0.019\n\n\n    Other\n1.18\n1.07, 1.31\n&lt;0.001\n\n\n    Private\n1.04\n0.96, 1.11\n0.3\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.85\n0.79, 0.90\n&lt;0.001\n\n\n    South\n1.11\n1.05, 1.17\n&lt;0.001\n\n\n    West\n1.08\n1.01, 1.15\n0.021\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.15\n1.09, 1.20\n&lt;0.001\n\n\n    Small\n1.09\n1.03, 1.15\n0.003\n\n\nHospital location/teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.14\n1.03, 1.25\n0.008\n\n\n    Urban, teaching\n1.10\n1.01, 1.21\n0.025\n\n\nKidney transplant Hx\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.83\n0.74, 0.95\n0.005\n\n\nRenal_Dialysis\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.61\n0.59, 0.63\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.43\n1.38, 1.48\n&lt;0.001\n\n\nCerebrovascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.24\n1.18, 1.31\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.85\n0.81, 0.88\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.97\n0.93, 1.01\n0.2\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.50\n1.44, 1.56\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.56\n0.52, 0.60\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.99\n0.94, 1.03\n0.6\n\n\nCharlson comorbidity index\n1.05\n1.04, 1.06\n&lt;0.001\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nGastrointestinal Hemorrhage:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR1\n95% CI1\np-value\n\n\n\n\nObstructive sleep apnea status\n\n\n\n\n\n\n\n\n    Renal Failure without OSA\n—\n—\n\n\n\n\n    Renal Failure with OSA\n1.01\n0.98, 1.05\n0.3\n\n\nAge, y\n1.02\n1.02, 1.02\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.96\n0.94, 0.98\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.11\n1.05, 1.16\n&lt;0.001\n\n\n    Black\n1.14\n1.11, 1.16\n&lt;0.001\n\n\n    Hispanic\n0.98\n0.95, 1.02\n0.3\n\n\n    Other\n1.00\n0.95, 1.05\n0.9\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.97\n0.95, 1.00\n0.021\n\n\n    $66,000 - $87,999\n1.00\n0.97, 1.02\n0.9\n\n\n    $88,000 or more\n0.98\n0.95, 1.01\n0.12\n\n\nInsurance payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n1.14\n1.10, 1.18\n&lt;0.001\n\n\n    Other\n0.99\n0.92, 1.05\n0.7\n\n\n    Private\n1.08\n1.03, 1.13\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.94\n0.90, 0.97\n&lt;0.001\n\n\n    South\n0.93\n0.91, 0.96\n&lt;0.001\n\n\n    West\n0.96\n0.93, 1.0\n0.023\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n1.00\n0.97, 1.02\n0.9\n\n\n    Small\n0.97\n0.95, 1.00\n0.045\n\n\nHospital location/teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.07\n1.02, 1.13\n0.007\n\n\n    Urban, teaching\n1.10\n1.05, 1.15\n&lt;0.001\n\n\nKidney transplant Hx\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.95\n0.89, 1.01\n0.10\n\n\nRenal_Dialysis\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.82\n0.80, 0.83\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.03\n1.01, 1.05\n0.002\n\n\nCerebrovascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.75\n0.73, 0.78\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.82, 0.86\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.59\n0.57, 0.60\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.78, 0.81\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.87\n0.84, 0.91\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.98\n0.95, 1.00\n0.068\n\n\nCharlson comorbidity index\n1.19\n1.18, 1.19\n&lt;0.001\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Impact of Obstructive Sleep Apnea on In-Hospital Outcomes in Patients with Renal Failure",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI1\np-value\n\n\n\n\nObstructive sleep apnea status\n\n\n\n\n\n\n\n\n    Renal Failure without OSA\n—\n—\n\n\n\n\n    Renal Failure with OSA\n-0.40\n-0.47, -0.33\n&lt;0.001\n\n\nAge, y\n0.01\n0.01, 0.01\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.17\n0.13, 0.22\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n-0.08\n-0.22, 0.07\n0.3\n\n\n    Black\n-0.03\n-0.10, 0.04\n0.4\n\n\n    Hispanic\n-0.30\n-0.40, -0.19\n&lt;0.001\n\n\n    Other\n0.18\n0.03, 0.32\n0.020\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.02\n-0.09, 0.06\n0.7\n\n\n    $66,000 - $87,999\n0.02\n-0.06, 0.11\n0.6\n\n\n    $88,000 or more\n0.11\n0.01, 0.21\n0.039\n\n\nInsurance payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n-0.86\n-0.99, -0.73\n&lt;0.001\n\n\n    Other\n-0.57\n-0.78, -0.37\n&lt;0.001\n\n\n    Private\n-0.28\n-0.43, -0.13\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.98\n0.81, 1.1\n&lt;0.001\n\n\n    South\n0.52\n0.39, 0.64\n&lt;0.001\n\n\n    West\n0.07\n-0.07, 0.22\n0.3\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-0.87\n-0.98, -0.76\n&lt;0.001\n\n\n    Small\n-1.4\n-1.5, -1.3\n&lt;0.001\n\n\nHospital location/teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.97\n0.82, 1.1\n&lt;0.001\n\n\n    Urban, teaching\n1.9\n1.8, 2.1\n&lt;0.001\n\n\nKidney transplant Hx\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.4\n-1.5, -1.3\n&lt;0.001\n\n\nRenal_Dialysis\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-3.3\n-3.4, -3.2\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.48\n-0.53, -0.43\n&lt;0.001\n\n\nCerebrovascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.6\n1.5, 1.7\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.66\n-0.72, -0.60\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.86\n-0.93, -0.79\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.51\n0.45, 0.57\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.6\n-1.8, -1.4\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.56\n0.50, 0.63\n&lt;0.001\n\n\nCharlson comorbidity index\n0.43\n0.40, 0.45\n&lt;0.001\n\n\n\n1 CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI1\np-value\n\n\n\n\nObstructive sleep apnea status\n\n\n\n\n\n\n\n\n    Renal Failure without OSA\n—\n—\n\n\n\n\n    Renal Failure with OSA\n-10,378\n-11,738, -9,018\n&lt;0.001\n\n\nAge, y\n-256\n-298, -215\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n6,244\n5,396, 7,092\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n9,319\n5,123, 13,515\n&lt;0.001\n\n\n    Black\n-1,810\n-3,533, -86\n0.040\n\n\n    Hispanic\n9,831\n7,034, 12,627\n&lt;0.001\n\n\n    Other\n10,152\n5,763, 14,541\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n994\n-737, 2,726\n0.3\n\n\n    $66,000 - $87,999\n2,353\n257, 4,449\n0.028\n\n\n    $88,000 or more\n10,744\n7,497, 13,992\n&lt;0.001\n\n\nInsurance payer\n\n\n\n\n\n\n\n\n    Medicaid\n—\n—\n\n\n\n\n    Medicare\n3,477\n1,093, 5,862\n0.004\n\n\n    Other\n-1,959\n-5,535, 1,617\n0.3\n\n\n    Private\n21,069\n17,325, 24,812\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n26,694\n21,284, 32,105\n&lt;0.001\n\n\n    South\n15,694\n12,405, 18,984\n&lt;0.001\n\n\n    West\n47,113\n40,556, 53,670\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-19,351\n-23,175, -15,528\n&lt;0.001\n\n\n    Small\n-31,098\n-35,105, -27,091\n&lt;0.001\n\n\nHospital location/teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n34,749\n31,342, 38,155\n&lt;0.001\n\n\n    Urban, teaching\n50,929\n47,513, 54,345\n&lt;0.001\n\n\nKidney transplant Hx\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-23,881\n-26,929, -20,832\n&lt;0.001\n\n\nRenal_Dialysis\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-51,065\n-53,828, -48,302\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2,315\n1,188, 3,441\n&lt;0.001\n\n\nCerebrovascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n25,176\n23,046, 27,306\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-11,913\n-13,227, -10,599\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-20,345\n-22,204, -18,486\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n5,818\n4,465, 7,171\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-29,851\n-34,454, -25,248\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n10,607\n9,270, 11,943\n&lt;0.001\n\n\nCharlson comorbidity index\n6,129\n5,609, 6,649\n&lt;0.001\n\n\n\n1 CI = Confidence Interval"
  }
]